Which description correctly defines sympathomimetics?

Which description correctly defines sympathomimetics?

• A. Drugs that mimic catecholamines such as epinephrine, norepinephrine, and dopamine
• B. Drugs that block adrenergic receptors to reduce sympathetic activity
• C. Substances that enhance parasympathetic transmission
• D. Medications that inhibit dopamine synthesis in the brain

Answer: (A)

Sympathomimetics produce effects that imitate activation of the sympathetic nervous system by acting like endogenous catecholamines or by increasing their action. The best description is drugs that mimic catecholamines such as epinephrine, norepinephrine, and dopamine, because these agents trigger the same adrenergic receptor pathways as the body's own catecholamines. They can work directly as receptor agonists or indirectly by promoting release or blocking reuptake of catecholamines. The other options describe blocking sympathetic activity, enhancing parasympathetic signaling, or reducing dopamine synthesis—not actions that define sympathomimetics.

Sympathomimetics produce effects that imitate activation of the sympathetic nervous system by acting like endogenous catecholamines or by increasing their action. The best description is drugs that mimic catecholamines such as epinephrine, norepinephrine, and dopamine, because these agents trigger the same adrenergic receptor pathways as the body's own catecholamines. They can work directly as receptor agonists or indirectly by promoting release or blocking reuptake of catecholamines. The other options describe blocking sympathetic activity, enhancing parasympathetic signaling, or reducing dopamine synthesis—not actions that define sympathomimetics.